X, P., Z, Z., L, L., L, B., R, T., H, Y., & L, Z. (2022, August). Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges. Drug Design, Development and Therapy.
Chicago Style (17th ed.) CitationX, Peng, Zhao Z, Liu L, Bai L, Tong R, Yang H, and Zhong L. "Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges." Drug Design, Development and Therapy Aug. 2022.
MLA (9th ed.) CitationX, Peng, et al. "Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges." Drug Design, Development and Therapy, Aug. 2022.
Warning: These citations may not always be 100% accurate.
